EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort

Marcello Arca, Paolo Calabrò, Anna Solini, Angela Pirillo, Rosanna Gambacurta, Kausik K Ray, Alberico L Catapano, SANTORINI Italian Group

Nutrition, Metabolism and Cardiovascular Diseases · 2026-02 · 36 (2) · 104412

DOI: 10.1016/j.numecd.2025.104412 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-02. Verfasst von Marcello Arca und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational and Precision Medicine, Sapienza, University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Cholesterol, LDL, Dyslipidemias, Cardiovascular Diseases, Anticholesteremic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Daiichi Sankyo Europe GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Cardiovascular disease continues to be the leading cause of death worldwide, with atherosclerotic cardiovascular disease (ASCVD) being a major contributor. Elevated low-density lipoprotein cholesterol (LDL-C) levels are an important risk factor, which led to updated guidelines from the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) in 2019 recommending lower LDL-C goals for patients at high- and very high-risk. However, many patients do not achieve the recommended LDL-C levels. The SANTORINI study was initiated to evaluate lipid management across Europe. This report presents the results of the 1-year follow-up of the Italian cohort. METHODS AND RESULTS: The study included 2095 patients, with 1993 having 1-year follow-up data. At baseline, 32 % of patients were not receiving lipid-lowering therapy (LLT), decreasing to 2.1 % at follow-up. Monotherapy use increased from 34.2 % to 41.0 %, while combination therapy use increased from 33.8 % to 55.5 %, particularly with high-intensity statin and ezetimibe combinations. LDL-C levels decreased from 2.5 to 1.9 mmol/L overall, with a greater reduction in very high-risk patients. The proportion of patients achieving LDL-C goals increased from 20.8 % to 35.0 %. Cardiovascular events were more frequent in very high-risk patients, with 11 cardiovascular deaths and 80 major adverse cardiovascular events (MACE). CONCLUSION: The Italian cohort of the SANTORINI study demonstrated improved LLT usage and LDL-C management, with a shift towards combination therapy. Despite these improvements, only one-third of patients achieved guideline-recommended LDL-C goals, highlighting the need to further optimise lipid-lowering strategies to reduce cardiovascular risk. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04271280.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesterol, LDLDyslipidemiasCardiovascular DiseasesAnticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsPractice Patterns, Physicians'HumansItalyMaleFemaleMiddle AgedAgedBiomarkersTreatment OutcomeTime FactorsRisk AssessmentDrug Therapy, CombinationGuideline AdherenceRisk Factors

Stichwörter der Autor:innen

AssessmentAtherosclerotic cardiovascular diseaseCardiovascular riskGuidelinesLDL-CholesterolLipid-lowering therapy

Substanzen

Cholesterol, LDLBiomarkersAnticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Translational and Precision Medicine, Sapienza, University of Rome, Rome, Italy.
  • Division of Cardiology Sant'Anna and S. Sebastiano Hospital, University of Campania Luigi Vanvitelli, Caserta, Italy.
  • University of Pisa School of Medicine, Pisa, Italy.
  • Center for the Study of Atherosclerosis, E. Bassini Hospital, Cinisello Balsamo, Milan, Italy.
  • Medical Affairs at Daiichi Sankyo Italy, Rome, Italy.
  • Imperial Centre for Cardiovascular Disease Prevention, ICTU-Global, Imperial College London, London, United Kingdom.

Förderung

  • Daiichi Sankyo Europe GmbH

Zitieren

APA

Arca, M., Calabrò, P., Solini, A., Pirillo, A., Gambacurta, R., Ray, K. K., Catapano, A. L., & SANTORINI Italian Group (2026). Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort. Nutrition, Metabolism and Cardiovascular Diseases, 36(2), 104412. https://doi.org/10.1016/j.numecd.2025.104412

Vancouver

Arca M, Calabrò P, Solini A, Pirillo A, Gambacurta R, Ray KK, et al. Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(2):104412. doi:10.1016/j.numecd.2025.104412

BibTeX
@article{Arca2026,
  author = {Arca, Marcello and Calabrò, Paolo and Solini, Anna and Pirillo, Angela and Gambacurta, Rosanna and Ray, Kausik K and Catapano, Alberico L and SANTORINI Italian Group, SANTORINI Italian Group},
  title = {Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  volume = {36},
  number = {2},
  pages = {104412},
  doi = {10.1016/j.numecd.2025.104412}
}
Kostenlos starten →